Intrapleural BCG in postsurgical stage I non-small cell lung cancer
Related Experiment Videos
P Macchiarini1, A Mussi, C A Angeletti
1Service of Thoracic Surgery, University of Pisa, Italy.
Anticancer Research
|March 1, 1989
Abstract:
In a randomized trial comparing intrapleural bacillus Calmette-Guérin (BCG) with placebo in postsurgical stage I non-small cell lung cancer, BCG-treated patients (n = 17) showed a non-significant overall improvement of 5-year and median survival and disease-free interval, but an increased rate of recurrence of cancer compared with control patients (n = 17).